N-acetylglutamate Synthase: Structure, Function & Defects
N-乙酰谷氨酸合成酶:结构、功能
基本信息
- 批准号:9261515
- 负责人:
- 金额:$ 35.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAddressAffectAffinity ChromatographyAffinity LabelsAmmoniaArginineBindingBinding SitesBiochemicalBioinformaticsBiological AssayBiologyBloodBrainBrain InjuriesCarbamyl PhosphateCell membraneCellsCloningCo-ImmunoprecipitationsCrystallizationDNADefectDevelopmentDiagnosisDistalDoseElementsEnzymesEpithelialEpithelial CellsEvolutionFundingGene ProteinsGenesGenetic TranscriptionGenotypeGlutamatesHepatocyteHomology ModelingHumanHyperammonemiaIntestinesIntronsInvestigationKnockout MiceKnowledgeLifeLigandsLigaseLiverLiver MitochondriaLiver diseasesMammalsMass Spectrum AnalysisMediatingMetabolicMethodsMitochondriaMitochondrial MatrixMolecular DiagnosisMusN acetyl L glutamateN-carbamylglutamateN-terminalNitrogenNucleic Acid Regulatory SequencesPatientsPhenotypePhysiologicalPlayPost-Translational RegulationProductionProteinsRegulationReporterResearchResistanceRoleSmall Interfering RNAStructureSystemTertiary Protein StructureTestingToxic effectTranscriptional RegulationTransfectionTransgenesUntranslated RNAUreaWorkX-Ray Crystallographyaffinity labelinganalogchromatin immunoprecipitationclinically relevanthuman diseaseimprovedin vivoinhibitor/antagonistinsightknock-downmetabolic phenotypemouse modelmutantnew therapeutic targetnitrogen metabolismnovelnovel strategiespolyprolinepromoterprotein protein interactionpublic health relevancethree dimensional structuretooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): This project focuses on the regulation of the N-acetylglutamate synthase (NAGS) gene and its enzyme product which catalyzes the formation of N-acetylglutamate (NAG). While carbamyl phosphate synthetase 1 (CPS1) is often referred to as the first and rate-limiting enzyme of ureagenesis, it requires NAG as an essential allosteric activator. Therefore, the levels of NAG in the mitochondrial matrix of liver and small intestinal epithelial cells play an important role in regulating urea production. This NAGS/NAG system is an emerging target for new treatment of hyperammonemia. New tools that were developed during the previous funding periods will allow us to address many important questions about this system, its clinical relevance, and how it can be exploited to develop new approaches for managing and treating hyperammonemia. The specific aims of this project are to: Aim 1 - Characterize the transcriptional regulation of NAGS and its role in human disease. In this aim we will elucidate the functional importance of two conserved non-coding sequences of the NAGS gene in the regulation of its transcription. This will be accomplished by studying liver and intestine derived cells and by using bioinformatics, reporter, chromatin immunoprecipitation and DNA-pull-down assays. Aim 2 - Determine the structural basis and physiological role of mammalian NAGS activation by L-arginine. This aim will explore (a) structural and mechanistic correlates of the positive regulatory effect of L-arginine on NAGS activity at the protein level by using x-ray crystallography of mammalian NAGS with and without bound substrates and (b) in vivo effect on ureagenesis and other metabolic parameters of arginine activation of NAGS in koNAGS mouse by transfection with arginine-insensitive and sensitive NAGS transgenes. Aim 3 - Characterize the structural and functional interactions between the N-terminus of NAGS and CPS1. This aim will use X-ray crystallography to determine the structural basis of NAGS-CPS1 interaction, and the koNAGS mouse transfected with various NAGS mutants will be studied to identify alterations in nitrogen metabolism that will reveal the functional importance of this interaction. Aim 4 - Determine the mechanism of N-carbamylglutamate (NCG) delivery to hepatocyte and intestinal cell mitochondria. This aim will use affinity labeling and siRNA knock down methods to identify transporters that are involved in delivery of NCG to liver and intestinal cell mitochondria. Overall, the project uses new tools of research to gain new insights into a system that can be exploited for better diagnosis and treatment of NAGS deficiency and other conditions associated with hyperammonemia.
描述(由申请人提供):该项目重点关注N-乙酰谷氨酸合酶(NAGS)基因及其催化N-乙酰谷氨酸(NAG)形成的酶产物的调控。虽然氨甲酰磷酸合成酶 1 (CPS1) 通常被称为尿素生成的第一个限速酶,但它需要 NAG 作为必需的变构激活剂。因此,肝脏和小肠上皮细胞线粒体基质中NAG的水平在调节尿素生成中发挥重要作用。该 NAGS/NAG 系统是高氨血症新治疗的新兴靶标。在之前的资助期间开发的新工具将使我们能够解决有关该系统、其临床相关性以及如何利用它来开发管理和治疗高氨血症的新方法的许多重要问题。该项目的具体目标是: 目标 1 - 表征 NAGS 的转录调控及其在人类疾病中的作用。为此,我们将阐明 NAGS 基因的两个保守非编码序列在其转录调控中的功能重要性。这将通过研究肝脏和肠道来源的细胞并使用生物信息学、报告基因、染色质免疫沉淀和 DNA 下拉测定来实现。目标 2 - 确定 L-精氨酸激活哺乳动物 NAGS 的结构基础和生理作用。该目标将通过使用有或没有结合底物的哺乳动物 NAGS 的 X 射线晶体学,探索 (a) L-精氨酸在蛋白质水平上对 NAGS 活性的正调节作用的结构和机制相关性,以及 (b) 对尿素生成的体内影响以及通过转染精氨酸不敏感和敏感 NAGS 转基因在 koNAGS 小鼠中精氨酸激活 NAGS 的其他代谢参数。目标 3 - 表征 NAGS 的 N 末端和 CPS1 之间的结构和功能相互作用。该目标将使用 X 射线晶体学来确定 NAGS-CPS1 相互作用的结构基础,并且将研究用各种 NAGS 突变体转染的 koNAGS 小鼠,以确定氮代谢的变化,从而揭示这种相互作用的功能重要性。目标 4 - 确定 N-氨甲酰谷氨酸 (NCG) 递送至肝细胞和肠细胞线粒体的机制。该目标将使用亲和标记和 siRNA 敲除方法来识别参与将 NCG 递送至肝和肠细胞线粒体的转运蛋白。总体而言,该项目使用新的研究工具来获得对系统的新见解,该系统可用于更好地诊断和治疗 NAGS 缺乏症以及与高氨血症相关的其他疾病。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
基因传递纠正了 N-乙酰谷氨酸合酶缺陷,并能够深入了解 L-精氨酸激活 N-乙酰谷氨酸合酶的生理影响。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:4.6
- 作者:Sonaimuthu, P;Senkevitch, E;Haskins, N;Uapinyoying, P;McNutt, M;Morizono, H;Tuchman, M;Caldovic, L
- 通讯作者:Caldovic, L
Transcriptional regulation of N-acetylglutamate synthase.
N-乙酰谷氨酸合酶的转录调控。
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Heibel, Sandra Kirsch;Lopez, Giselle Yvette;Panglao, Maria;Sodha, Sonal;Mariño;Tuchman, Mendel;Caldovic, Ljubica
- 通讯作者:Caldovic, Ljubica
N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
由于 N-乙酰谷氨酸合酶增强子区域中的重复序列变异导致 N-乙酰谷氨酸合酶缺陷。
- DOI:
- 发表时间:2018
- 期刊:
- 影响因子:4.6
- 作者:Williams, Monique;Burlina, Alberto;Rubert, Laura;Polo, Giulia;Ruijter, George J G;van den Born, Myrthe;Rüfenacht, Véronique;Haskins, Nantaporn;van Zutven, Laura J C M;Tuchman, Mendel;Saris, Jasper J;Häberle, Johannes;Caldovic, Ljubica
- 通讯作者:Caldovic, Ljubica
A novel bifunctional N-acetylglutamate synthase-kinase from Xanthomonas campestris that is closely related to mammalian N-acetylglutamate synthase.
一种来自野油菜黄单胞菌的新型双功能 N-乙酰谷氨酸合酶激酶,与哺乳动物 N-乙酰谷氨酸合酶密切相关。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Qu, Qiuhao;Morizono, Hiroki;Shi, Dashuang;Tuchman, Mendel;Caldovic, Ljubica
- 通讯作者:Caldovic, Ljubica
Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.
罕见疾病的精准医学:N-氨甲酰-L-谷氨酸对突变型 CPS1 酶的不同作用机制。
- DOI:
- 发表时间:2017
- 期刊:
- 影响因子:3.8
- 作者:Shi, Dashuang;Zhao, Gengxiang;Ah Mew, Nicholas;Tuchman, Mendel
- 通讯作者:Tuchman, Mendel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ljubica Morizono Caldovic其他文献
Ljubica Morizono Caldovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ljubica Morizono Caldovic', 18)}}的其他基金
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
解码小鼠 Pkhd1 模型中的肾脏保护机制:对 ARPKD 治疗的影响
- 批准号:
10614404 - 财政年份:2020
- 资助金额:
$ 35.88万 - 项目类别:
Neuroprotection from hyperammonemia: small molecule screen
高氨血症的神经保护:小分子筛选
- 批准号:
8670740 - 财政年份:2013
- 资助金额:
$ 35.88万 - 项目类别:
Neuroprotection from hyperammonemia: small molecule screen
高氨血症的神经保护:小分子筛选
- 批准号:
8567762 - 财政年份:2013
- 资助金额:
$ 35.88万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration
代谢和表观遗传调控是转分化和血管再生的结合体
- 批准号:
10905167 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
Spatial Acetyl-CoA metabolism as a regulator of Hallmarks of Aging
空间乙酰辅酶A代谢作为衰老标志的调节剂
- 批准号:
10901039 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
- 批准号:
10387520 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
- 批准号:
10548816 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Engineering of a mouse model of choline acetycholinesterase deficients using CRISPR/Cas9 gene editing
使用 CRISPR/Cas9 基因编辑构建胆碱乙酰胆碱酯酶缺陷小鼠模型
- 批准号:
10511979 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别: